The Digital Health Podcast with Fexingo: Wearables, Diagnostics, and Health Software

Lucas and Luna explore how companies like DayTwo and Viome are using machine learning to analyze the gut microbiome and generate personalized food recommendations. They break down the science of metagenomic sequencing, the challenge of translating microbial data into actionable diet plans, and why the FDA is paying close attention. With specific numbers on trial outcomes and cost barriers, this episode digs into whether AI-powered nutrition is ready for the mainstream or still a rich person's experiment.

#GutMicrobiome #PrecisionNutrition #DayTwo #Viome #MetagenomicSequencing #MachineLearning #AIinHealthcare #DigitalHealth #PersonalizedMedicine #FDA #ClinicalTrials #NutritionScience #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #HealthTech #StartupFunding #Microbiome

Keep every episode free: buymeacoffee.com/fexingo

In this episode of Digital Health Podcast, Lucas and Luna explore how machine learning models are mining electronic health records to detect sepsis hours before visible symptoms appear. They focus on the case of Epic's Sepsis Model, which analyzes over 200 variables in real time to flag patients at risk. Lucas explains why sepsis is the deadliest condition in hospitals, claiming 270,000 lives annually in the US alone, and how early detection can reduce mortality by 30 percent. Luna questions the false alarm problem — the model's high sensitivity often floods nurses with alerts, causing alert fatigue. They discuss how a 2024 JAMA study found that the Epic model reduced sepsis mortality by only 0.2 percent when deployed without workflow changes, and why combining AI with a dedicated response team made the difference. The hosts also touch on regulatory hurdles, the cost of implementation, and whether smaller hospitals can afford these systems. By the end, listeners understand that the technology works, but only if hospitals redesign how they respond.

#SepsisDetection #AIinHealthcare #ElectronicHealthRecords #EpicSystems #MachineLearning #HealthTech #ClinicalDecisionSupport #AlertFatigue #JAMA #PatientSafety #DigitalHealth #PredictiveAnalytics #HospitalTech #Business #Technology #FexingoBusiness #BusinessPodcast #DigitalHealthPodcast

Keep every episode free: buymeacoffee.com/fexingo

In this episode of The Digital Health Podcast, Lucas and Luna explore how artificial intelligence is being used to predict which patients will be readmitted to the hospital within 30 days of discharge — before they even leave the building. They focus on a specific case: a machine learning model deployed at Mount Sinai Health System that analyzes electronic health record data, social determinants of health, and real-time vital signs to assign a readmission risk score. The model reportedly reduced 30-day readmissions by 15% in a pilot study, saving an estimated $4 million in avoidable costs. The hosts discuss the model's key features — like natural language processing of discharge notes — and the challenges of integrating AI into clinical workflows without overwhelming nurses. They also touch on the broader trend of hospitals moving from reactive to predictive care, and what it means for patients and insurers. A natural, specific conversation about a real-world application of digital health technology.

#AI #DigitalHealth #HospitalReadmissions #MachineLearning #MountSinai #PredictiveAnalytics #Healthcare #EHR #NaturalLanguageProcessing #ClinicalDecisionSupport #PatientOutcomes #CostReduction #Medicare #HealthTech #RiskStratification #Business #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna unpack the quiet revolution in health insurance underwriting: how AI models are analyzing everything from smartwatch step counts to grocery purchase data to calculate personalized risk scores. They walk through a real case study where one major insurer cut claims costs by 18 percent in a pilot program by using wearable data to incentivize preventive care. But they also dig into the ethical minefield — what happens when your Fitbit data makes your premium go up? With specific numbers from a 2025 JAMA study and the growing regulatory push in California, this episode is a grounded look at how AI is reshaping the trillion-dollar insurance industry, one data point at a time.

#AI #HealthInsurance #Wearables #RiskScoring #Underwriting #PreventiveCare #DataPrivacy #JAMA #CaliforniaRegulation #InsuranceTech #Business #Technology #HealthTech #DigitalHealth #FexingoBusiness #BusinessPodcast #Podcast #LucasAndLuna

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna dive into the emerging field of AI-powered retinal imaging, where a simple eye scan can detect signs of Alzheimer's, diabetes, and cardiovascular risk years before symptoms appear. They explore how Google Health's algorithm for diabetic retinopathy achieved FDA clearance in 2020, and how newer models are predicting age-related macular degeneration and systemic diseases from retinal photographs. The hosts discuss the accuracy of these tools — some studies show 90% sensitivity for certain conditions — and the hurdles of integrating them into routine primary care. They also touch on the privacy implications of storing retinal data in the cloud and the potential for false positives. This episode offers a clear-eyed look at a technology that could make annual eye exams a front line for preventive medicine.

#RetinalImaging #AIinHealthcare #GoogleHealth #DiabeticRetinopathy #AlzheimersDetection #PreventiveMedicine #Ophthalmology #MachineLearning #MedicalAI #HealthTech #EarlyDiagnosis #DigitalHealth #EyeHealth #Biomarkers #Business #Technology #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

In this episode, Lucas and Luna dive into how consumer smartwatches are becoming frontline tools for detecting atrial fibrillation, a heart condition that affects over 33 million people globally and is a leading cause of stroke. They explore a landmark 2025 study from the Stanford Center for Digital Health that analyzed data from over 400,000 Apple Watch users, showing that the device's photoplethysmography sensor can flag irregular pulses with 84% sensitivity compared to clinical ECG patches. The hosts discuss how this compares to traditional screening methods, why false positives remain a challenge, and what cardiologists think about patients showing up with watch data. They also touch on the FDA's evolving stance on over-the-counter health algorithms and how the UK's National Health Service is piloting watch-based monitoring for high-risk patients. The episode centers on whether this shift from reactive to continuous passive screening will reduce stroke rates or just flood clinics with worried well people.

#AtrialFibrillation #SmartwatchHealth #AppleWatch #PPGSensor #StanfordStudy #DigitalHealth #Cardiology #StrokePrevention #WearableECG #FHAScreening #ClinicalValidation #NHSPilot #ContinuousMonitoring #HealthTech #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #ScienceAndData

Keep every episode free: buymeacoffee.com/fexingo

In this episode, Lucas and Luna explore how smart rings — tiny wearable computers you wear on your finger — are quietly becoming the next frontier in continuous health monitoring. They break down the key players: Oura, the Finnish company that started the category, and newcomers like Samsung and Amazfit. Lucas shares how Oura's latest generation tracks everything from heart rate variability to skin temperature to overnight blood oxygen, all in a form factor many users find more comfortable than a wristwatch. They discuss the clinical validation challenge: smart rings face the same FDA scrutiny as other medical devices, but their smaller size means batteries and sensors must be miniaturized without sacrificing accuracy. Luna asks whether smart rings will replace smartwatches or coexist, and Lucas points to the data: Oura has sold over 2 million rings and is now partnering with employers and insurers for wellness programs. The hosts also touch on privacy concerns around continuous biometric data collection and whether consumers truly understand what they're consenting to. A concrete, grounded look at a category that's growing fast but flying under many people's radar.

#SmartRings #Oura #Wearables #HealthTech #DigitalHealth #Samsung #Amazfit #ContinuousMonitoring #HRV #SleepTracking #Biometrics #Privacy #HealthData #WearableTech #FitnessTech #Business #BusinessPodcast #FexingoBusiness

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore how pharmaceutical companies and startups are using artificial intelligence to find new therapeutic uses for drugs already approved for other conditions. They focus on a specific case: a 2025 study where an AI model screened 4,000 existing compounds and identified a common blood pressure medication as a potential treatment for a rare genetic liver disease — cutting the typical discovery timeline from years to months. The hosts discuss the economics of repurposing versus developing new drugs, the data infrastructure needed, and why this approach could reshape how we think about pharmaceutical R&D. No hype — just the real mechanics of computational drug repurposing and what it means for patients and investors.

#DrugDiscovery #AIinHealthcare #PharmaceuticalR&D #DrugRepurposing #MachineLearning #ComputationalBiology #RareDisease #ClinicalTrials #HealthTech #Biotech #PharmaInnovation #PrecisionMedicine #DataScience #GenerativeAI #LifeSciences #Business #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore the emerging field of breath-based diagnostics, focusing on how companies like Owlstone Medical are developing portable 'breathalyzers' that detect volatile organic compounds linked to lung cancer, asthma, and even infectious diseases. They discuss how this non-invasive technology could transform screening in primary care, the regulatory hurdles it faces, and the specific biomarkers being validated in clinical trials as of mid-2026. A concrete look at a technology that promises cheaper, faster, and more comfortable diagnosis.

#BreathAnalysis #MedTech #Diagnostics #OwlstoneMedical #VolatileOrganicCompounds #LungCancerScreening #NonInvasiveDiagnosis #DigitalHealth #HealthTech #Biomarkers #PrimaryCare #ClinicalTrials #RegulatoryHurdles #FDA #PointOfCare #EarlyDetection #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

In this episode, Lucas and Luna explore how artificial intelligence is analyzing speech patterns to detect mental health conditions like depression, anxiety, and PTSD. They discuss a landmark study from the University of Vermont that achieved 85% accuracy in identifying depression from voice recordings alone. The conversation covers how AI models can detect subtle acoustic biomarkers—pitch, tempo, breathiness—that clinicians might miss, the startups building commercial tools like Sonde Health and Kintsugi, and the ethical concerns around privacy and consent. Tune in to understand how your voice could become a vital sign for mental wellness.

#MentalHealth #VoiceAI #DigitalHealth #AI #DepressionDetection #SpeechAnalysis #SondeHealth #Kintsugi #UniversityOfVermont #AcousticBiomarkers #Business #Technology #FexingoBusiness #BusinessPodcast #HealthTech #AIinHealthcare #MentalWellness #Startup

Keep every episode free: buymeacoffee.com/fexingo